POMALIDOMIDE — all Canadian products
28 DINs
24 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is POMALIDOMIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02520451 | APO-POMALIDOMIDE | APOTEX INC | Capsule | Oral | POMALIDOMIDE 4 MG | Marketed | |
| 02520443 | APO-POMALIDOMIDE | APOTEX INC | Capsule | Oral | POMALIDOMIDE 3 MG | Marketed | |
| 02520435 | APO-POMALIDOMIDE | APOTEX INC | Capsule | Oral | POMALIDOMIDE 2 MG | Marketed | |
| 02520427 | APO-POMALIDOMIDE | APOTEX INC | Capsule | Oral | POMALIDOMIDE 1 MG | Marketed | |
| 02538091 | JAMP POMALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | Oral | POMALIDOMIDE 4 MG | Marketed | |
| 02538083 | JAMP POMALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | Oral | POMALIDOMIDE 3 MG | Marketed | |
| 02538075 | JAMP POMALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | Oral | POMALIDOMIDE 2 MG | Marketed | |
| 02538059 | JAMP POMALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | Oral | POMALIDOMIDE 1 MG | Marketed | |
| 02506394 | NAT-POMALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | Oral | POMALIDOMIDE 1 MG | Marketed | |
| 02506408 | NAT-POMALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | Oral | POMALIDOMIDE 2 MG | Marketed | |
| 02506416 | NAT-POMALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | Oral | POMALIDOMIDE 3 MG | Marketed | |
| 02506424 | NAT-POMALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | Oral | POMALIDOMIDE 4 MG | Marketed | |
| 02419580 | POMALYST | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | POMALIDOMIDE 1 MG | Marketed | |
| 02419599 | POMALYST | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | POMALIDOMIDE 2 MG | Marketed | |
| 02419602 | POMALYST | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | POMALIDOMIDE 3 MG | Marketed | |
| 02419610 | POMALYST | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | POMALIDOMIDE 4 MG | Marketed | |
| 02504073 | REDDY-POMALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | Oral | POMALIDOMIDE 1 MG | Marketed | |
| 02504081 | REDDY-POMALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | Oral | POMALIDOMIDE 2 MG | Marketed | |
| 02504111 | REDDY-POMALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | Oral | POMALIDOMIDE 4 MG | Marketed | |
| 02504103 | REDDY-POMALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | Oral | POMALIDOMIDE 3 MG | Marketed | |
| 02524007 | SANDOZ POMALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | Oral | POMALIDOMIDE 3 MG | Marketed | |
| 02523973 | SANDOZ POMALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | Oral | POMALIDOMIDE 1 MG | Marketed | |
| 02523981 | SANDOZ POMALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | Oral | POMALIDOMIDE 2 MG | Marketed | |
| 02524015 | SANDOZ POMALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | Oral | POMALIDOMIDE 4 MG | Marketed | |
| 02517086 | POMALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | Oral | POMALIDOMIDE 3 MG | Cancelled Pre Market | |
| 02517094 | POMALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | Oral | POMALIDOMIDE 4 MG | Cancelled Pre Market | |
| 02517051 | POMALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | Oral | POMALIDOMIDE 1 MG | Cancelled Pre Market | |
| 02517078 | POMALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | Oral | POMALIDOMIDE 2 MG | Cancelled Pre Market |
Browse other molecules: